[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
{{output}}
Background: Neuroblastoma is an aggressive paediatric malignancy with poor outcomes in high-risk patients despite multimodal therapy. [177Lu]Lu-DOTATATE, targeting somatostatin receptor 2 (SSTR2), is under clinical investigation ... ...
